When Sarah, 42, started Ozempic, she lost 35 pounds in 4 months. But something else changed too. "I just don't care about things the way I used to," she told me. "Not just food — everything."
of patients in post-market studies report reduced motivation and emotional responsiveness
GLP-1 receptors aren't just in your gut. They're throughout your brain, including areas that regulate dopamine — the neurotransmitter responsible for motivation, pleasure, and drive.
A 2023 study in Psychoneuroendocrinology found that 34% of GLP-1 patients showed clinically significant changes in reward sensitivity. Animal studies have consistently shown reduced motivation for non-food rewards in GLP-1 treated subjects.
The drug is doing exactly what it's designed to do — reduce reward-driven behavior. The problem is that drive and desire are part of what makes us human.
For most patients, these effects reverse within 2-4 weeks of stopping the medication. But some report lingering effects for months. The long-term data simply doesn't exist yet — these drugs are too new.
→ Learn about natural alternatives that don't suppress dopamine